Risk of new-onset inflammatory bowel disease among patients with acne vulgaris exposed to isotretinoin.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

Data on the risk of inflammatory bowel disease (IBD) among isotretinoin-exposed patients with acne vulgaris (AV) is controversial.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): J Am Acad Dermatol

Title: Journal of the American Academy of Dermatology

Publisher: Elsevier BV

ISSN (Electronic): 1097-6787

ISSN (Print): 0190-9622

Publication date (Electronic): Jan 2021

Volume: 84

Issue: 1

Affiliations

[1 ] Department of Dermatology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, New York.

[2 ] Department of Dermatology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, New York. Electronic address: amgarg@northwell.edu.

Article

Publisher Item ID: S0190-9622(20)32211-8

DOI: 10.1016/j.jaad.2020.07.042

PubMed ID: 32682881

SO-VID: 7c5aa019-a265-4408-8ffc-9a99e5a9fb0b

History

Keywords: Explorys,risk,isotretinoin,inflammatory bowel disease,acne vulgaris

Data availability:

Keywords: Explorys, risk, isotretinoin, inflammatory bowel disease, acne vulgaris

Risk of new-onset inflammatory bowel disease among patients with acne vulgaris exposed to isotretinoin.

Read this article at

Abstract

Related collections

Karger: Gastroenterology

Author and article information

Journal

Affiliations

Article

History

Comments

Comment on this article

Cited by 7